Akademska digitalna zbirka SLovenije - logo

Search results

Basic search    Expert search   

Currently you are NOT authorised to access e-resources SI consortium. For full access, REGISTER.

1 2 3 4 5
hits: 617
1.
  • Myeloablative Versus Reduce... Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Scott, Bart L; Pasquini, Marcelo C; Logan, Brent R ... Journal of clinical oncology, 04/2017, Volume: 35, Issue: 11
    Journal Article
    Peer reviewed
    Open access

    Purpose The optimal regimen intensity before allogeneic hematopoietic cell transplantation (HCT) is unknown. We hypothesized that lower treatment-related mortality (TRM) with reduced-intensity ...
Full text
Available for: NUK, UL, UM, UPUK

PDF
2.
  • Pembrolizumab in Relapsed a... Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study
    Khodadoust, Michael S; Rook, Alain H; Porcu, Pierluigi ... Journal of clinical oncology, 01/2020, Volume: 38, Issue: 1
    Journal Article
    Peer reviewed
    Open access

    To assess the efficacy of pembrolizumab in patients with advanced relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS). CITN-10 is a single-arm, multicenter phase II trial of 24 ...
Full text
Available for: NUK, UL, UM, UPUK

PDF
3.
Full text
4.
  • Brentuximab vedotin or phys... Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
    Prince, H Miles, Prof; Kim, Youn H, Prof; Horwitz, Steven M, MD ... The Lancet (British edition), 08/2017, Volume: 390, Issue: 10094
    Journal Article
    Peer reviewed

    Summary Background Cutaneous T-cell lymphomas are rare, generally incurable, and associated with reduced quality of life. Present systemic therapies rarely provide reliable and durable responses. We ...
Full text
Available for: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK, ZRSKP
5.
  • 2019 NCCN Consensus Guideli... 2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
    Clemens, Mark W; Jacobsen, Eric D; Horwitz, Steven M Aesthetic surgery journal, 01/2019, Volume: 39, Issue: Supplement_1
    Journal Article
    Peer reviewed
    Open access

    Abstract National Comprehensive Cancer Network (NCCN) guidelines represent the consensus standard of care for diagnosis and management of the majority of known cancers. NCCN guidelines on breast ...
Full text
Available for: NUK, UL, UM, UPUK

PDF
6.
  • Multisystem Inflammatory Sy... Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
    Feldstein, Leora R; Rose, Erica B; Horwitz, Steven M ... New England journal of medicine/˜The œNew England journal of medicine, 07/2020, Volume: 383, Issue: 4
    Journal Article
    Peer reviewed
    Open access

    This report describes the epidemiology and clinical course of patients younger than 21 years of age from 26 states who had multisystem inflammatory syndrome. Many were infected with SARS-CoV-2 at ...
Full text
Available for: CMK, UL

PDF
7.
  • How I treat breast implant–... How I treat breast implant–associated anaplastic large cell lymphoma
    Mehta-Shah, Neha; Clemens, Mark W.; Horwitz, Steven M. Blood, 11/2018, Volume: 132, Issue: 18
    Journal Article
    Peer reviewed
    Open access

    Breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) is a recently described form of T-cell non-Hodgkin lymphoma now formally recognized by the World Health Organization classification ...
Full text
Available for: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UILJ, UL, UM, UPCLJ, UPUK, ZAGLJ, ZRSKP

PDF
8.
  • NCCN Consensus Guidelines f... NCCN Consensus Guidelines for the Diagnosis and Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma
    Clemens, Mark W; Horwitz, Steven M Aesthetic surgery journal, 03/2017, Volume: 37, Issue: 3
    Journal Article, Conference Proceeding
    Peer reviewed
    Open access

    Published case series demonstrate a lack of treatment standardization for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) with a wide variety of therapeutic strategies being ...
Full text
Available for: NUK, UL, UM, UPUK

PDF
9.
  • Risk of breast implant asso... Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants
    Cordeiro, Peter G.; Ghione, Paola; Ni, Andy ... Journal of plastic, reconstructive & aesthetic surgery, 05/2020, Volume: 73, Issue: 5
    Journal Article
    Peer reviewed
    Open access

    The risk of BIA-ALCL for patients with textured breast implants has been estimated between 1/2832 and 1/30,000 women. Existing studies estimating the numbers exposed and at risk, may have under ...
Full text
Available for: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UILJ, UL, UM, UPCLJ, UPUK, ZAGLJ, ZRSKP

PDF
10.
  • Characteristics and Outcome... Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
    Feldstein, Leora R; Tenforde, Mark W; Friedman, Kevin G ... JAMA, 03/2021, Volume: 325, Issue: 11
    Journal Article
    Peer reviewed
    Open access

    IMPORTANCE: Refinement of criteria for multisystem inflammatory syndrome in children (MIS-C) may inform efforts to improve health outcomes. OBJECTIVE: To compare clinical characteristics and outcomes ...
Full text
Available for: CMK

PDF
1 2 3 4 5
hits: 617

Load filters